Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers

BackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surfa...

Full description

Bibliographic Details
Main Authors: Guanyong Ou, Ling Qing, Li Zhang, Yang Yang, Guoguo Ye, Ling Peng, Yanjie Li, Liuqing Yang, Yingxia Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/full
_version_ 1797289722235584512
author Guanyong Ou
Guanyong Ou
Ling Qing
Ling Qing
Li Zhang
Li Zhang
Yang Yang
Guoguo Ye
Ling Peng
Yanjie Li
Liuqing Yang
Yingxia Liu
author_facet Guanyong Ou
Guanyong Ou
Ling Qing
Ling Qing
Li Zhang
Li Zhang
Yang Yang
Guoguo Ye
Ling Peng
Yanjie Li
Liuqing Yang
Yingxia Liu
author_sort Guanyong Ou
collection DOAJ
description BackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surface antigen (HBsAg)-positive mothers is essential.Methods100 infants born to HBsAg-positive mothers from 2015 to 2020 were enrolled in the study, further divided into the non/low response group (n=13) and the moderate strong response group (n=87) based on the quantification of hepatitis B surface antibody at 12 months of age. The differential expression of 48 immune-related cytokines in the two groups was compared and analyzed in detail. The key cytokines were further identified and clinically predictive models were developed.ResultsWe found that 13 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group, compared with the moderate strong response group at birth. In addition, 9 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group at 12 months of age. Furthermore, we found that IL-5 and HGF were promising predictors for predicting the immunization response to hepatitis B vaccine in infants, and the combination of the two cytokines showed the best predictive efficiency, with an area under the curve (AUC) value of 0.844.ConclusionThe present study provides a theoretical basis on cytokines for developing and implementing effective immunotherapies against non/low immune response in infants born to HBsAg-positive mothers.
first_indexed 2024-03-07T19:10:07Z
format Article
id doaj.art-29d3676485e44441b7c6c53b0652a7d7
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-03-07T19:10:07Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-29d3676485e44441b7c6c53b0652a7d72024-03-01T04:55:15ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-03-011410.3389/fcimb.2024.13326661332666Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothersGuanyong Ou0Guanyong Ou1Ling Qing2Ling Qing3Li Zhang4Li Zhang5Yang Yang6Guoguo Ye7Ling Peng8Yanjie Li9Liuqing Yang10Yingxia Liu11National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaSchool of Medicine, Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaGraduate Collaborative Training Base of Shenzhen Third People’s Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaGraduate Collaborative Training Base of Shenzhen Third People’s Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, ChinaBackgroundThe immune response to hepatitis B vaccine may be influenced by numerous factors, and patients with non/low response re-exposed to hepatitis B virus remain susceptible. Thus, a better understanding of the underlying mechanisms of non/low immune response in infants born to Hepatitis B surface antigen (HBsAg)-positive mothers is essential.Methods100 infants born to HBsAg-positive mothers from 2015 to 2020 were enrolled in the study, further divided into the non/low response group (n=13) and the moderate strong response group (n=87) based on the quantification of hepatitis B surface antibody at 12 months of age. The differential expression of 48 immune-related cytokines in the two groups was compared and analyzed in detail. The key cytokines were further identified and clinically predictive models were developed.ResultsWe found that 13 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group, compared with the moderate strong response group at birth. In addition, 9 cytokines were lowly expressed and one cytokine was highly expressed in the non/low response group at 12 months of age. Furthermore, we found that IL-5 and HGF were promising predictors for predicting the immunization response to hepatitis B vaccine in infants, and the combination of the two cytokines showed the best predictive efficiency, with an area under the curve (AUC) value of 0.844.ConclusionThe present study provides a theoretical basis on cytokines for developing and implementing effective immunotherapies against non/low immune response in infants born to HBsAg-positive mothers.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/fullhepatitis B vaccineimmune responseinfantcytokineIL-5HGF
spellingShingle Guanyong Ou
Guanyong Ou
Ling Qing
Ling Qing
Li Zhang
Li Zhang
Yang Yang
Guoguo Ye
Ling Peng
Yanjie Li
Liuqing Yang
Yingxia Liu
Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
Frontiers in Cellular and Infection Microbiology
hepatitis B vaccine
immune response
infant
cytokine
IL-5
HGF
title Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
title_full Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
title_fullStr Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
title_full_unstemmed Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
title_short Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers
title_sort cytokine il 5 and hgf combined prediction of non low immune response to hepatitis b vaccination at birth in infants born to hbsag positive mothers
topic hepatitis B vaccine
immune response
infant
cytokine
IL-5
HGF
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1332666/full
work_keys_str_mv AT guanyongou cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT guanyongou cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT lingqing cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT lingqing cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT lizhang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT lizhang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT yangyang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT guoguoye cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT lingpeng cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT yanjieli cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT liuqingyang cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers
AT yingxialiu cytokineil5andhgfcombinedpredictionofnonlowimmuneresponsetohepatitisbvaccinationatbirthininfantsborntohbsagpositivemothers